Moreover, Shakhar G. et al. have shown that β-AR agonism remarkably suppresses NK activity and this compromises host resistance to mammary adenocarcinoma MADB106, an NK-sensitive tumor, in rats (60). Here, ADRB2 is linked to neoplasm.